Items 1 to 10 of about 45188
1. Coughlin SS: Community-Based Participatory Research Studies on HIV/AIDS Prevention, 2005-2014. Jacobs J Community Med; 2016 Apr;2(1)

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Community-Based Participatory Research Studies on HIV/AIDS Prevention, 2005-2014.
  • Published HIV prevention studies that employed CBPR methods were identified for the period January 1, 2005 to April 30, 2014 using PubMed databases and MeSH term and keyword searches.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AIDS Patient Care STDS. 2012 Feb;26(2):116-24 [22149766.001]
  • [Cites] J Pediatr Psychol. 2006 Oct;31(9):905-16 [16452646.001]
  • [Cites] J Empir Res Hum Res Ethics. 2013 Apr;8(2):119-28 [23651936.001]
  • [Cites] Prog Community Health Partnersh. 2009 Winter;3(4):275-6 [20097988.001]
  • [Cites] AIDS Educ Prev. 2010 Jun;22(3):173-83 [20528127.001]
  • [Cites] AIDS Care. 2007 Jul;19(6):799-810 [17573601.001]
  • [Cites] Cult Health Sex. 2010 Oct;12(7):797-812 [20582764.001]
  • [Cites] AIDS Educ Prev. 2010 Jun;22(3):184-202 [20528128.001]
  • [Cites] Asia Pac J Public Health. 2010 Jul;22(3 Suppl):151S-158S [20566548.001]
  • [Cites] J Prev Interv Community. 2010;38(2):104-17 [20391058.001]
  • [Cites] Health Care Women Int. 2011 Apr;32(4):300-13 [21409663.001]
  • [Cites] AIDS Behav. 2013 May;17 Suppl 1:S33-42 [22903420.001]
  • [Cites] Health Promot Pract. 2011 Nov;12(6):823-31 [21511996.001]
  • [Cites] AIDS Behav. 2011 Nov;15(8):1764-75 [21301948.001]
  • [Cites] Promot Educ. 2007;14(3):150-4 [18154224.001]
  • [Cites] J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18644 [24242259.001]
  • [Cites] Cult Health Sex. 2011 Oct;13(9):1073-89 [21815839.001]
  • [Cites] Int Public Health J. 2012;4(3):301-308 [24489998.001]
  • [Cites] Contemp Clin Trials. 2010 Mar;31(2):151-6 [20035899.001]
  • [Cites] AIDS Educ Prev. 2010 Aug;22(4):371-85 [20707696.001]
  • [Cites] Health Promot Pract. 2011 Mar;12(2):293-302 [20685913.001]
  • [Cites] AIDS Educ Prev. 2007 Dec;19(6):531-44 [18190277.001]
  • [Cites] Am J Public Health. 2011 Apr;101(4):623-31 [20558812.001]
  • [Cites] Soc Sci Med. 2012 Aug;75(4):699-708 [22647562.001]
  • [Cites] AIDS Patient Care STDS. 2007 Nov;21(11):861-70 [18240895.001]
  • [Cites] Prog Community Health Partnersh. 2011 Winter;5(4):425-31 [22616210.001]
  • [Cites] Prev Sci. 2011 Mar;12(1):34-47 [21107693.001]
  • [Cites] AIDS Educ Prev. 2009 Oct;21(5 Suppl):103-8 [19824838.001]
  • [Cites] Ethn Dis. 2010 Winter;20(1 Suppl 2):S2-1-8 [20629240.001]
  • [Cites] Health Promot Pract. 2013 Jul;14(4):607-16 [23075504.001]
  • [Cites] Prog Community Health Partnersh. 2012 Winter;6(4):417-27 [23221286.001]
  • [Cites] Am J Health Behav. 2012 Jul;36(4):555-68 [22488405.001]
  • [Cites] AIDS Educ Prev. 2010 Feb;22(1):37-48 [20166786.001]
  • [Cites] AIDS Care. 2006 May;18(4):398-403 [16809119.001]
  • [Cites] BMC Public Health. 2012 Aug 20;12:677 [22905910.001]
  • [Cites] AIDS Care. 2006 Nov;18(8):1018-24 [17012094.001]
  • [Cites] Soc Sci Med. 2009 Jan;68(1):12-20 [18952342.001]
  • [Cites] Sex Transm Dis. 2013 Mar;40(3):264-70 [23403607.001]
  • [Cites] J Empir Res Hum Res Ethics. 2012 Oct;7(4):34-43 [23086046.001]
  • [Cites] Patient Educ Couns. 2011 Dec;85(3):454-60 [21208772.001]
  • [Cites] J Acquir Immune Defic Syndr. 2013 Jun 1;63 Suppl 1:S32-5 [23673883.001]
  • [Cites] AIDS Care. 2011 Jun;23 Suppl 1:66-74 [21660752.001]
  • [Cites] Public Health Rep. 2010 Jan-Feb;125 Suppl 1:29-37 [20408385.001]
  • [Cites] Technol Innov. 2012 Apr 1;13(4):null [24353757.001]
  • [Cites] Am J Mens Health. 2011 Mar;5(2):140-51 [20413391.001]
  • [Cites] J Community Health. 2011 Jun;36(3):486-94 [21107895.001]
  • [Cites] Health Educ Behav. 2011 Jun;38(3):311-20 [21393625.001]
  • [Cites] AIDS Educ Prev. 2010 Jun;22(3):252-71 [20528132.001]
  • [Cites] Prog Community Health Partnersh. 2007 Summer;1(2):161-8 [20208235.001]
  • [Cites] Soc Sci Med. 2008 Feb;66(4):911-21 [18155336.001]
  • [Cites] J Urban Health. 2010 Jul;87(4):617-30 [20361357.001]
  • [Cites] AIDS Educ Prev. 2010 Jun;22(3):203-17 [20528129.001]
  • [Cites] Womens Health Issues. 2012 May-Jun;22(3):e293-301 [22483581.001]
  • [Cites] AIDS Educ Prev. 2010 Jun;22(3):218-37 [20528130.001]
  • [Cites] J Transcult Nurs. 2009 Jan;20(1):28-36 [18955506.001]
  • [Cites] J Empir Res Hum Res Ethics. 2013 Feb;8(1):68-78 [23485672.001]
  • [Cites] Int Q Community Health Educ. 2010;31(2):133-54 [21840812.001]
  • [Cites] Harm Reduct J. 2007 Dec 08;4:20 [18067670.001]
  • [Cites] Soc Work. 2010 Jan;55(1):19-26 [20069937.001]
  • [Cites] J Health Care Poor Underserved. 2010 Aug;21(3 Suppl):148-68 [20675952.001]
  • [Cites] AIDS Educ Prev. 2011 Jun;23(3):236-48 [21696242.001]
  • [Cites] Prog Community Health Partnersh. 2012 Winter;6(4):451-6 [23221290.001]
  • [Cites] AIDS Educ Prev. 2012 Feb;24(1):41-53 [22339144.001]
  • [Cites] J Relig Health. 2014 Aug;53(4):1223-35 [24639068.001]
  • (PMID = 28066841.001).
  • [Journal-full-title] Jacobs journal of community medicine
  • [ISO-abbreviation] Jacobs J Community Med
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / R29 HL044904; United States / NHLBI NIH HHS / HL / R29 HL044904-05
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Acquired Immune Deficiency Syndrome / African Americans / American Indians / Asians and Pacific Islanders / Community-Based Participatory Research / HIV / Hispanics
  •  go-up   go-down


2. Lau MS, Dalziel BD, Funk S, McClelland A, Tiffany A, Riley S, Metcalf CJ, Grenfell BT: Spatial and temporal dynamics of superspreading events in the 2014-2015 West Africa Ebola epidemic. Proc Natl Acad Sci U S A; 2017 Feb 28;114(9):2337-2342

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spatial and temporal dynamics of superspreading events in the 2014-2015 West Africa Ebola epidemic.
  • The unprecedented scale of the Ebola outbreak in Western Africa (2014-2015) has prompted an explosion of efforts to understand the transmission dynamics of the virus and to analyze the performance of possible containment strategies.
  • Models have focused primarily on the reproductive numbers of the disease that represent the average number of secondary infections produced by a random infectious individual.
  • However, these population-level estimates may conflate important systematic variation in the number of cases generated by infected individuals, particularly found in spatially localized transmission and superspreading events.
  • We also show that community-based cases may have progressed more rapidly than those notified within clinical-care systems, and most transmission events occurred in a relatively short distance (with median value of 2.51 km).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 2005 Nov 17;438(7066):293-5 [16292292.001]
  • [Cites] Lancet Infect Dis. 2015 May;15(5):507-8 [25932579.001]
  • [Cites] N Engl J Med. 2015 Feb 5;372(6):584-7 [25539446.001]
  • [Cites] Proc Biol Sci. 2003 Jan 22;270(1511):121-7 [12590749.001]
  • [Cites] Ann Intern Med. 2015 Jan 6;162(1):11-7 [25347321.001]
  • [Cites] Epidemiol Infect. 2008 Feb;136(2):241-7 [17394674.001]
  • [Cites] J R Soc Interface. 2015 Nov 6;12 (112): [26559683.001]
  • [Cites] Euro Surveill. 2015 Jun 25;20(25):14-8 [26132768.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):20-7 [25590682.001]
  • [Cites] Am Nat. 2004 Aug;164(2):267-81 [15278849.001]
  • [Cites] PLoS Comput Biol. 2012;8(11):e1002768 [23166481.001]
  • [Cites] N Engl J Med. 2014 Oct 16;371(16):1481-95 [25244186.001]
  • [Cites] J Hyg (Lond). 1985 Jun;94(3):365-436 [4008922.001]
  • [Cites] Elife. 2015 Dec 08;4:null [26646185.001]
  • [Cites] Science. 2006 Apr 21;312(5772):447-51 [16574822.001]
  • [Cites] N Engl J Med. 2015 Jan 1;372(1):40-7 [25372658.001]
  • [Cites] PLoS Comput Biol. 2012;8(3):e1002413 [22412361.001]
  • [Cites] PLoS Curr. 2015 Feb 10;7:null [25737806.001]
  • [Cites] PLoS Curr. 2014 Sep 02;6:null [25642364.001]
  • [Cites] Am J Epidemiol. 2002 May 1;155(9):866-74 [11978592.001]
  • [Cites] PLoS Curr. 2014 Sep 08;6:null [25642358.001]
  • [Cites] J R Soc Interface. 2014 Feb 12;11(93):20131093 [24522782.001]
  • [Cites] Euro Surveill. 2015 Jun 25;20(25):7-13 [26132767.001]
  • [Cites] PLoS Comput Biol. 2015 Nov 23;11(11):e1004633 [26599399.001]
  • [Cites] PLoS Curr. 2014 Oct 06;6:null [25642370.001]
  • [Cites] N Engl J Med. 2014 Sep 25;371(13):1180-3 [25140855.001]
  • [Cites] Sci Rep. 2015 Mar 04;5:8751 [25736239.001]
  • [Cites] Nature. 2005 Nov 17;438(7066):355-9 [16292310.001]
  • [Cites] Proc Biol Sci. 2008 Apr 22;275(1637):887-95 [18230598.001]
  • [Cites] Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):4170-5 [27001840.001]
  • [Cites] Lancet Infect Dis. 2015 Mar;15(3):320-6 [25619149.001]
  • (PMID = 28193880.001).
  • [ISSN] 1091-6490
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] eng
  • [Grant] United Kingdom / Medical Research Council / / MR/J008761/1; United States / NICHD NIH HHS / HD / P2C HD047879; United States / NIGMS NIH HHS / GM / U01 GM110721
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Bayesian inference / Ebola / offspring distribution / superspreading
  •  go-up   go-down


3. Santos VC, Anjos KF, Boery RN, Moreira RM, Cruz DP, Boery EN: Hospitalization and hospital mortality of elderly people with mental and behavioral disorders in Brazil, 2008-2014. Epidemiol Serv Saude; 2017 Jan-Mar;26(1):39-49

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hospitalization and hospital mortality of elderly people with mental and behavioral disorders in Brazil, 2008-2014.
  • [Transliterated title] Internação e mortalidade hospitalar de idosos por transtornos mentais e comportamentais no Brasil, 2008-2014.
  • OBJECTIVE:: to analyze the evolution of hospitalizations and hospital mortality of elderly people with mental and behavioral disorders in Brazil, from 2008 to 2014.
  • RESULTS:: during the studied period, 139,941 hospitalizations and 2,962 deaths were recorded; the hospitalization coefficient for mental and behavioral disorders decreased in Brazil, from 122.3 to 84.2 per 100 thousand inhabitants (-0.14%; 95%CI -0.25;-0.03), and its macroregions, except the South, which presented stationary trend (0.08%; 95%CI -0.11;0.27); the hospital mortality coefficients in Brazil, in 2008 and 2014, were, respectively, 1.73 and 2.38 per 100 thousand inhabitants; dementia was the main diagnosis in hospitalizations that registered deaths (32.3%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28226007.001).
  • [ISSN] 2237-9614
  • [Journal-full-title] Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil
  • [ISO-abbreviation] Epidemiol Serv Saude
  • [Language] por; eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


4. Li J, Tang HL, Han J, Xu J, Shen ZY, Lai WW, Shi YH, Sun DY, Ni MJ, Mao YR: [HIV transmission in newly reported HIV infected couples before diagnoses in five provinces, China, 2011-2014]. Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Nov 10;37(11):1497-1502
MedlinePlus Health Information. consumer health - HIV/AIDS in Women.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [HIV transmission in newly reported HIV infected couples before diagnoses in five provinces, China, 2011-2014].
  • <b>Methods:</b> The information about newly reported HIV infected couples in Yunnan, Guangxi, Sichuan, Henan and Xinjiang provinces (autonomous region) were collected from National HIV/AIDS Information System from 2011 to 2014.
  • Multivariate logistic regression analysis showed that those who were females (<i>OR</i>=1.98, 95%<i>CI</i>: 1.89-2.08), aged >45 years (45-59 yrs: <i>OR</i>=1.32, 95% <i>CI</i>: 1.23-1.42; >60 yrs: <i>OR</i>=1.72, 95% <i>CI</i>: 1.58-1.86), had educational level of middle school education or below (illiteracy and primary school: <i>OR</i>=1.33, 95%<i>CI</i>: 1.23-1.44; middle school: <i>OR</i>=1.19, 95% <i>CI</i>: 1.10-1.28), were farmers or migrate workers (<i>OR</i>=1.23, 95% <i>CI</i>: 1.17-1.30), were infected through injecting drug use or heterosexual intercourse (injecting drug use: <i>OR</i>=1.33, 95% <i>CI</i>: 1.03-1.72; heterosexual intercourse: <i>OR</i>=3.65, 95% <i>CI</i>: 2.89-4.61), had CD<sub>4</sub><sup>+</sup>T cells of <500 cells/μl (<200 cells/μl: <i>OR</i>=5.05, 95%<i>CI</i>: 4.62-5.52; 200-349 cells/μl: <i>OR</i>=3.58, 95%<i>CI</i>: 3.26-3.93; 350-500 cells/μl: <i>OR</i>=2.14, 95%<i>CI</i>: 1.94-2.36), reported unprotected sexual behaviors (<i>OR</i>=1.56, 95% <i>CI</i>: 1.49-1.64), were more likely to infect their couples before diagnosis.
  • The HIV transmission proportion between couples before diagnosis decreased significantly from 28.9% (2 631/9 102) in 2011 to 25.5% (3 009/11 787) in 2014 among those infected through heterosexual intercourse.

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28057142.001).
  • [ISSN] 0254-6450
  • [Journal-full-title] Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
  • [ISO-abbreviation] Zhonghua Liu Xing Bing Xue Za Zhi
  • [Language] chi
  • [Publication-type] Journal Article
  • [Publication-country] China
  •  go-up   go-down


5. Cohen ME, Hathway JM, Salmasian H, Liu J, Terry M, Abrams JA, Freedberg DE: Prophylaxis for Stress Ulcers With Proton Pump Inhibitors Is Not Associated With Increased Risk of Bloodstream Infections in the Intensive Care Unit. Clin Gastroenterol Hepatol; 2017 Jul;15(7):1030-1036.e1

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We performed a retrospective cohort study of adults (≥18 years) admitted to 1 of 14 ICUs within a hospital network of 3 large hospitals from 2008 through 2014.
  • After adjusting for potential confounders, PPI exposure was not associated with increased risk of BSI while in the ICU (adjusted hazard ratio, 1.08; 95% confidence interval, 0.91-1.29).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.
  • [Cites] MBio. 2014 Sep 23;5(5):e01361-14 [25249279.001]
  • [Cites] Gut. 1994 Apr;35(4):455-60 [8174980.001]
  • [Cites] Antimicrob Agents Chemother. 2013 May;57(5):2326-32 [23478961.001]
  • [Cites] Intensive Care Med. 2015 May;41(5):833-45 [25860444.001]
  • [Cites] Am J Gastroenterol. 2012 Apr;107(4):507-20; quiz 521 [22290403.001]
  • [Cites] Clin Gastroenterol Hepatol. 2016 Jun;14(6):809-815.e1 [26538205.001]
  • [Cites] Infection. 2014 Oct;42(5):875-81 [25030309.001]
  • [Cites] Am J Respir Crit Care Med. 1998 Aug;158(2):444-51 [9700119.001]
  • [Cites] Crit Care Med. 2011 Aug;39(8):1859-65 [21499086.001]
  • [Cites] J Chronic Dis. 1987;40(5):373-83 [3558716.001]
  • [Cites] Int J Neurosci. 2014 Jul;124(7):503-8 [24200298.001]
  • [Cites] Clin Transl Sci. 2011 Oct;4(5):338-45 [22029805.001]
  • [Cites] Nat Rev Microbiol. 2013 Apr;11(4):227-38 [23435359.001]
  • [Cites] Crit Care Med. 2004 Oct;32(10):2014-20 [15483409.001]
  • [Cites] Clin Microbiol Infect. 1997 Aug;3(4):395-396 [11864148.001]
  • [Cites] J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S25-7 [26447960.001]
  • [Cites] J Zhejiang Univ Sci B. 2014 Jan;15(1):58-66 [24390745.001]
  • [Cites] Gastroenterology. 2011 Oct;141(4):1314-22, 1322.e1-5 [21745447.001]
  • [Cites] Am J Health Syst Pharm. 1999 Feb 15;56(4):347-79 [10690219.001]
  • [Cites] Science. 2016 Apr 29;352(6285):565-9 [27126040.001]
  • [Cites] Clin Microbiol Infect. 2013 Jun;19(6):501-9 [23473333.001]
  • [Cites] J Gastroenterol Hepatol. 2011 Mar;26(3):550-7 [21332551.001]
  • [Cites] Crit Care. 2011;15(2):R100 [21418635.001]
  • [Cites] N Engl J Med. 2006 Dec 28;355(26):2725-32 [17192537.001]
  • [Cites] Gastroenterology. 1993 Mar;104(3):890-5 [8440440.001]
  • [Cites] Intensive Care Med. 2012 Dec;38(12):1930-45 [23011531.001]
  • [Cites] Am J Vet Res. 2013 Feb;74(2):239-42 [23363348.001]
  • [Cites] Genet Mol Res. 2015 Jul 06;14(3):7490-501 [26214428.001]
  • [Cites] Intensive Care Med. 2014 Jan;40(1):11-22 [24141808.001]
  • [Cites] Am J Gastroenterol. 2016 Nov;111(11):1641-1648 [27575714.001]
  • [Cites] Aliment Pharmacol Ther. 2006 Jan 1;23(1):3-10 [16393275.001]
  • [Cites] Clin Gastroenterol Hepatol. 2015 Apr;13(4):753-9.e1-2 [25130937.001]
  • [Cites] Crit Care Med. 2009 Jul;37(7):2167-73; quiz 2180 [19487942.001]
  • [Cites] Science. 2016 Apr 29;352(6285):544-5 [27126037.001]
  • [Cites] Gastroenterology. 2015 Oct;149(4):883-5.e9 [26164495.001]
  • (PMID = 28110095.001).
  • [ISSN] 1542-7714
  • [Journal-full-title] Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • [ISO-abbreviation] Clin. Gastroenterol. Hepatol.
  • [Language] eng
  • [Grant] United States / NCRR NIH HHS / RR / KL2 RR024157; United States / NCATS NIH HHS / TR / KL2 TR000081; United States / NINR NIH HHS / NR / R01 NR010822
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Acid Suppression / Bacteremia / Critical Care / Intestinal Permeability
  •  go-up   go-down


6. Pancholy S, Patel G, Pancholy M, Nanavaty S, Coppola J, Kwan T, Patel T: Association Between Health Insurance Status and In-Hospital Outcomes After ST-Segment Elevation Myocardial Infarction. Am J Cardiol; 2017 Oct 01;120(7):1049-1054

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Using the Nationwide Inpatient Sample data from 2003 to 2014, hospitalizations with STEMI in patients 18 years of age and older were extracted.
  • Other independent predictors of in-hospital mortality were low household income (OR = 1.08, 95% CI 1.07 to 1.09; p <0.001), acute stroke (OR = 2.87, 95% CI 2.80 to 2.95; p <0.001), acute kidney injury (OR = 2.60, 95% CI 2.57 to 2.64; p <0.001), cardiac arrest (OR = 8.88, 95% CI 8.77 to 8.99; p <0.001), cardiogenic shock (OR = 5.81, 95% CI 5.74 to 5.88; p <0.001), requirement of pericardiocentesis (OR = 10.54, 95% CI 9.64 to 11.52; p <0.001), gastrointestinal bleeding (OR = 1.41, 95% CI 1.38 to 1.54; p <0.001), and pneumonia (OR = 1.43, 95% CI 1.41 to 1.45; p <0.001).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Inc. All rights reserved.
  • (PMID = 28823480.001).
  • [ISSN] 1879-1913
  • [Journal-full-title] The American journal of cardiology
  • [ISO-abbreviation] Am. J. Cardiol.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


7. Friesen KJ, Chateau D, Falk J, Alessi-Severini S, Bugden S: Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia. BMC Infect Dis; 2017 Jan 13;17(1):69
MedlinePlus Health Information. consumer health - Shingles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Administrative healthcare data collected over the period of April 1<sup>st</sup> 1997 to March 31<sup>st</sup> 2014 were analyzed to determine the healthcare system burden of HZ using direct medical costs.
  • Medical costs increased (p <0.0001) from $57.98/episode (95% CI; $55.26, $60.70) to $78.84/episode (95% CI; $74.08, $83.61).
  • CONCLUSION: A significant increase in annual number of HZ cases was observed, driven largely by demographic factors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Acad Dermatol. 1998 May;38(5 Pt 1):763-5 [9591824.001]
  • [Cites] Vaccine. 2002 Jun 7;20(19-20):2500-7 [12057605.001]
  • [Cites] J Pain Res. 2014 Mar 10;7:125-32 [24648752.001]
  • [Cites] Ther Adv Vaccines. 2015 Jul;3(4):109-20 [26478818.001]
  • [Cites] Vaccine. 2014 Oct 29;32(47):6319-24 [24099868.001]
  • [Cites] BMC Infect Dis. 2010 Aug 03;10:230 [20682044.001]
  • [Cites] J Pain. 2008 Jan;9(1 Suppl 1):S3-9 [18166460.001]
  • [Cites] Lancet. 2002 Aug 31;360(9334):678-82 [12241874.001]
  • [Cites] Vaccine. 2007 Oct 23;25(43):7598-604 [17889410.001]
  • [Cites] PLoS One. 2013 Jun 21;8(6):e66485 [23805224.001]
  • [Cites] BMC Infect Dis. 2011 Jun 16;11:173 [21679419.001]
  • [Cites] J Pain Res. 2016 Aug 03;9:543-50 [27536159.001]
  • [Cites] J Infect Dis. 2008 Mar 1;197 Suppl 2:S228-36 [18419402.001]
  • [Cites] Neurol Clin. 2008 Aug;26(3):675-97, viii [18657721.001]
  • [Cites] Clin Infect Dis. 2011 Feb 1;52(3):332-40 [21217180.001]
  • [Cites] Proc R Soc Med. 1965 Jan;58:9-20 [14267505.001]
  • [Cites] Vaccine. 2011 Nov 3;29(47):8580-4 [21939721.001]
  • [Cites] J Dermatol. 2012 Nov;39(11):902-8 [22670895.001]
  • [Cites] BMC Infect Dis. 2015 Aug 19;15:350 [26286598.001]
  • [Cites] Clin Infect Dis. 2012 Nov 15;55(10):1320-8 [22828595.001]
  • [Cites] Clin Infect Dis. 2007 Jan 1;44 Suppl 1:S1-26 [17143845.001]
  • [Cites] J Clin Virol. 2010 May;48 Suppl 1:S2-7 [20510263.001]
  • [Cites] Eur J Neurol. 2010 Sep;17(9):1113-e88 [20402746.001]
  • [Cites] BMC Infect Dis. 2011 Nov 01;11:302 [22044665.001]
  • [Cites] J Infect. 2002 May;44(4):211-9 [12099726.001]
  • [Cites] J Infect. 2013 Nov;67(5):463-9 [23872209.001]
  • [Cites] Epidemiol Infect. 2009 Jan;137(1):38-47 [18466661.001]
  • [Cites] Epidemiol Infect. 2001 Oct;127(2):305-14 [11693508.001]
  • [Cites] Vaccine. 2001 Apr 30;19(23-24):3076-90 [11312002.001]
  • [Cites] N Engl J Med. 2005 Jun 2;352(22):2271-84 [15930418.001]
  • [Cites] Epidemiol Infect. 2012 Nov;140(11):2096-109 [22230041.001]
  • [Cites] Eur J Health Econ. 2013 Dec;14(6):1015-26 [23271349.001]
  • [Cites] Epidemiol Infect. 2012 Jun;140(6):1131-40 [21906410.001]
  • [Cites] N Engl J Med. 2002 Aug 1;347(5):340-6 [12151472.001]
  • [Cites] Soc Sci Med. 2008 Jan;66(1):117-29 [17919795.001]
  • [Cites] J Infect Dis. 1996 Nov;174 Suppl 3:S314-9 [8896538.001]
  • [Cites] Mayo Clin Proc. 2011 Dec;86(12):1146-53 [21997577.001]
  • [Cites] Annu Rev Public Health. 2011;32:91-108 [21219160.001]
  • [Cites] BMC Fam Pract. 2011 Dec 06;12:136 [22145678.001]
  • [Cites] Epidemiol Infect. 2000 Dec;125(3):651-69 [11218215.001]
  • [Cites] Pain Res Manag. 2014 Nov-Dec;19(6):328-35 [25479151.001]
  • (PMID = 28086817.001).
  • [ISSN] 1471-2334
  • [Journal-full-title] BMC infectious diseases
  • [ISO-abbreviation] BMC Infect. Dis.
  • [Language] eng
  • [Grant] United States / AHRQ HHS / HS / U18 HS017918
  • [Publication-type] Journal Article; Observational Study
  • [Publication-country] England
  • [Keywords] NOTNLM ; Administrative data / Burden / Economics / Epidemiology / Herpes zoster / Postherpetic neuralgia
  •  go-up   go-down


8. Chaillon A, Essat A, Frange P, Smith DM, Delaugerre C, Barin F, Ghosn J, Pialoux G, Robineau O, Rouzioux C, Goujard C, Meyer L, Chaix ML, on behalf the ANRS PRIMO Cohort Study: Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategies. Retrovirology; 2017 Feb 21;14(1):15
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Spatiotemporal dynamics of HIV-1 transmission in France (1999-2014) and impact of targeted prevention strategies.
  • RESULTS: Sociodemographic, geographic, clinical, biological and pol sequence data from 1356 patients were collected between 1999 and 2014.
  • Overall, 387 individuals (28.5%) were involved in clusters: 156 patients (11.5%) in 78 dyads and 231 participants (17%) in 42 larger clusters (median size: 4, range 3-41).
  • Reconstruction of viral migrations across time suggests that Paris area was the major hub of dissemination of both subtype B and CRF02_AG epidemics.

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • MedlinePlus Health Information. consumer health - HIV/AIDS in Women.
  • LANL HIV Databases. LANL HIV Databases .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Emerg Infect Dis. 2012 Nov;18(11):1858-64 [23092706.001]
  • [Cites] J Infect Dis. 2007 Aug 1;196(3):377-83 [17597452.001]
  • [Cites] PLoS One. 2014 Jun 05;9(6):e98443 [24901437.001]
  • [Cites] Clin Infect Dis. 2015 Nov 1;61(9):1462-8 [26129754.001]
  • [Cites] Clin Infect Dis. 2016 Jul 1;63(1):101-7 [27174704.001]
  • [Cites] J Antimicrob Chemother. 2015 Jul;70(7):2084-9 [25885327.001]
  • [Cites] J Antimicrob Chemother. 2013 Nov;68(11):2626-31 [23798669.001]
  • [Cites] PLoS One. 2012;7(2):e31695 [22348121.001]
  • [Cites] J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):e164-6 [24135781.001]
  • [Cites] Clin Infect Dis. 2016 Mar 1;62(5):655-63 [26620652.001]
  • [Cites] J Math Biol. 2008 Mar;56(3):391-412 [17874105.001]
  • [Cites] J Clin Microbiol. 2014 Nov;52(11):4010-6 [25232163.001]
  • [Cites] Clin Infect Dis. 2014 Jul;59 Suppl 1:S7-S11 [24926037.001]
  • [Cites] AIDS. 2003 Dec 5;17(18):2635-43 [14685058.001]
  • [Cites] PLoS One. 2016 Mar 11;11(3):e0151478 [26967154.001]
  • [Cites] PLoS Med. 2013 Dec;10(12):e1001568; discussion e1001568 [24339751.001]
  • [Cites] Retrovirology. 2008 Aug 01;5:69 [18673538.001]
  • [Cites] Clin Infect Dis. 2013 Mar;56(6):880-7 [23223603.001]
  • [Cites] AIDS. 2015 Nov 28;29(18):2517-22 [26558547.001]
  • [Cites] AIDS. 2017 Jan 14;31(2):287-293 [27831950.001]
  • [Cites] Curr Opin Virol. 2011 Nov;1(5):423-9 [22440846.001]
  • [Cites] J Infect Dis. 2015 Mar 15;211(6):926-35 [25312037.001]
  • [Cites] AIDS. 2017 Jan 28;31(3):407-416 [27831948.001]
  • [Cites] AIDS. 1998 Feb 12;12(3):285-90 [9517991.001]
  • [Cites] AIDS Res Hum Retroviruses. 2014 Dec;30(12):1226-35 [25275430.001]
  • [Cites] Mol Biol Evol. 2012 Aug;29(8):1969-73 [22367748.001]
  • [Cites] J Infect Dis. 2011 Oct 1;204(7):1115-9 [21881127.001]
  • [Cites] AIDS. 2011 Mar 13;25(5):679-89 [21297424.001]
  • [Cites] AIDS. 2007 Nov 12;21(17):2323-32 [18090281.001]
  • [Cites] J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):545-52 [15793364.001]
  • [Cites] AIDS. 2009 Mar 27;23(6):717-24 [19279445.001]
  • [Cites] J Infect Dis. 2007 Apr 1;195(7):951-9 [17330784.001]
  • [Cites] Lancet HIV. 2016 May;3(5):e231-8 [27126490.001]
  • [Cites] Lancet. 2004 Jul 3-9;364(9428):83-94 [15234861.001]
  • [Cites] N Engl J Med. 2015 Dec 3;373(23):2237-46 [26624850.001]
  • [Cites] AIDS. 2010 Jan 16;24(2):271-82 [20010072.001]
  • [Cites] EBioMedicine. 2015 Jul 18;2(10):1456-63 [26629540.001]
  • [Cites] Lancet Infect Dis. 2010 Oct;10(10):682-7 [20832367.001]
  • [Cites] AIDS. 2010 May 15;24(8):1203-12 [20395786.001]
  • [Cites] J Acquir Immune Defic Syndr. 2010 Sep;55(1):102-8 [20622676.001]
  • [Cites] Sci Transl Med. 2010 Sep;2(50):501r1 [21532938.001]
  • [Cites] J Infect Dis. 2011 Nov;204(9):1463-9 [21921202.001]
  • [Cites] J Infect Dis. 2008 Sep 1;198(5):687-93 [18662132.001]
  • [Cites] PLoS One. 2013 Jun 28;8(6):e68188 [23840830.001]
  • [Cites] AIDS. 2006 Jan 9;20(2):159-70 [16511408.001]
  • [Cites] PLoS Med. 2008 Mar 18;5(3):e50 [18351795.001]
  • [Cites] AIDS. 1997 Oct;11(12):1503-8 [9342073.001]
  • [Cites] Infect Genet Evol. 2016 Dec;46:209-218 [27063411.001]
  • [Cites] J Int AIDS Soc. 2014 Jun 17;17:19034 [24942364.001]
  • [Cites] AIDS. 2009 Jan 14;23(2):225-32 [19098493.001]
  • [Cites] PLoS Comput Biol. 2009 Sep;5(9):e1000520 [19779555.001]
  • [Cites] Euro Surveill. 2009 Dec 03;14(48):null [20003900.001]
  • [Cites] J Infect Dis. 2014 Jan 15;209(2):304-13 [24151309.001]
  • [Cites] AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1046-1053 [27105549.001]
  • [Cites] J Int AIDS Soc. 2016 Oct 18;19(7(Suppl 6)):21103 [27760681.001]
  • [Cites] AIDS Res Hum Retroviruses. 2013 Sep;29(9):1265-72 [23742654.001]
  • [Cites] BMC Evol Biol. 2007 Nov 08;7:214 [17996036.001]
  • [Cites] Lancet. 2009 Jan 3;373(9657):48-57 [19038438.001]
  • [Cites] J Infect Dis. 2016 May 1;213(9):1410-8 [26704616.001]
  • [Cites] Clin Infect Dis. 2006 Mar 1;42(5):709-15 [16447119.001]
  • [Cites] Ann Epidemiol. 2009 Jun;19(6):423-31 [19460672.001]
  • (PMID = 28222757.001).
  • [ISSN] 1742-4690
  • [Journal-full-title] Retrovirology
  • [ISO-abbreviation] Retrovirology
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / K24 AI100665; United States / NIMH NIH HHS / MH / R01 MH101012; United States / NIDA NIH HHS / DA / R21 DA041007; United States / NIMH NIH HHS / MH / R25 MH081482; United States / NIAID NIH HHS / AI / K23 AI093163; United States / NIAID NIH HHS / AI / R01 AI120009; United States / NIAID NIH HHS / AI / U01 AI068636; United States / NIDA NIH HHS / DA / DP1 DA034978; United States / NIAID NIH HHS / AI / P30 AI027763; United States / NIMH NIH HHS / MH / P30 MH062512; United States / NIAID NIH HHS / AI / P30 AI036214; United States / NIMH NIH HHS / MH / R01 MH097520; United States / NIAID NIH HHS / AI / UM1 AI068636
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] England
  • [Chemical-registry-number] 0 / pol Gene Products, Human Immunodeficiency Virus
  • [Keywords] NOTNLM ; HIV-1 (major topic) / Phylogeography (major topic) / Primary infection (major topic) / Transmission network (major topic) / Treatment as prevention (major topic)
  •  go-up   go-down


9. Bekele T, Rueda S, Gardner S, Raboud J, Smieja M, Kennedy R, Fletcher D, Burchell AN, Bacon J, Rourke SB: Trends and Correlates of Cigarette Smoking and Its Impacts on Health-Related Quality of Life Among People Living with HIV: Findings from the Ontario HIV Treatment Network Cohort Study, 2008-2014. AIDS Patient Care STDS; 2017 Feb;31(2):49-59
MedlinePlus Health Information. consumer health - Smoking.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Trends and Correlates of Cigarette Smoking and Its Impacts on Health-Related Quality of Life Among People Living with HIV: Findings from the Ontario HIV Treatment Network Cohort Study, 2008-2014.
  • Self-report data on cigarette smoking, HRQOL, and demographic and sociobehavioral variables were collected between 2008 and 2014 through annual face-to-face interviews.
  • Smoking prevalence declined annually by 1.6% between 2008 and 2014, but remained much higher than the prevalence in the general population.
  • Current cigarette smokers also had significantly (p < 0.001) worse SF-12 physical component summary (β = -2.07) and SF-12 mental component summary (β = -1.08) scores than those who never smoked after adjusting for demographic, socioeconomic, and HIV-related clinical variables.


10. Yan BY, Zhang L, Lyu JJ, Feng Y, Liu JY, Wu WL, Song LZ, Xu AQ: [A sero-epidemiological study of hepatitis E among general population in Shandong Province of China in 2014]. Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul 06;51(7):587-592

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A sero-epidemiological study of hepatitis E among general population in Shandong Province of China in 2014].
  • <b>Methods:</b> The inhabitants aged between 1-59 years old were randomly selected to participate in the study by two-stage stratified random sampling method from 12 counties in Shandong province in October, 2014.
  • <b>Results:</b> A total of 5 229 subjects entered the final analysis in 2014.
  • The overall weighed prevalence of anti-HEV IgG was 9.19% (95<i>%CI:</i> 6.18%-12.20%) among natural population in Shandong province, decreased by 19.88% in comparison with that in 2006 sero-survey (11.47%, 95<i>%CI:</i> 8.92%-14.02%).
  • The prevalence increased with age increasing (χ(2trend)=288.11, <i>P<</i>0.001) in 2014, which was similar to the result in 2006 sero-survey.
  • The prevalence of anti-HEV IgG in urban (8.19%, 95<i>%CI:</i> 0.00-22.23%), rural areas (9.69%, 95<i>%CI:</i> 4.99%-14.38%), eastern areas (12.70%, 95<i>%CI:</i> 0.00-27.72%), central areas (4.74%, 95<i>%CI:</i> 0.00-9.91%) and western areas (9.32%, 95<i>%CI:</i> 0.69%-17.94%) in 2014 were all lower than the corresponding prevalences (11.39%, 95<i>%CI:</i> 8.17%-14.62%; 11.92%, 95<i>%CI:</i> 8.75%-15.08%; 22.77%, 95<i>%CI:</i> 14.99%-30.55%; 7.97%, 95<i>%CI:</i> 4.75%-11.20%; 10.59%, 95<i>%CI:</i> 6.37%-14.82%) in 2006 survey.
  • The prevalence of anti-HEV IgG in coastal areas (16.56%, 95<i>%CI:</i> 12.94%-20.18%) and inland areas (7.63%, 95<i>%CI:</i> 5.16%-10.10%) in 2014 were lower than it in the corresponding areas (28.04%, 95<i>%CI:</i> 20.45%-35.64%; 9.50%, 95<i>%CI:</i> 7.31%-11.70%) in 2006 survey.
  • The prevalence among peasant (11.98%, 95<i>%CI:</i> 8.20%-15.76%), worker (9.68%, 95<i>%CI:</i> 4.48%-14.88%), cadre (13.90%, 95<i>%CI:</i> 7.47%-20.33%), service provider (12.26%, 95<i>%CI:</i> 1.80%-22.73%) in 2014 survey were lower than it among the corresponding populations (13.76%, 95<i>%CI:</i> 10.15%-17.38%; 21.11%, 95<i>%CI:</i> 12.67%-29.55%; 17.81%, 95<i>%CI:</i> 7.63%-28.00%; 21.08%, 95<i>%CI:</i> 0.03%-42.12%) in 2006 survey.
  • <b>目的:</b> 分析山东省人群戊型肝炎流行现状,为戊型肝炎防控提供参考。 <b>方法:</b> 于2014年10月,在山东省12个县(市、区)采用两阶段分层随机抽样方法,选取1~59岁常住人口作为调查对象。首先采用概率比例规模抽样法在调查县(市、区)抽取2个行政村/社区居委会,按照最适分配分层随机抽样方法抽取1~59岁人群,开展问卷调查并采集静脉血标本3~5 ml,共5 229名。采用ELISA法检测戊型肝炎病毒(HEV)IgG抗体(抗-HEV IgG);采用抽样权重进行复杂抽样的抗-HEV IgG阳性率点值估计,采用泰勒级数线性法估计抗-HEV IgG阳性率的方差,然后构建估计值的95<i>%CI</i>。通过比较率点值的95<i>%CI</i>进行率的统计学检验。并与2006年山东省戊型肝炎血清流行病学调查结果相比较。 <b>结果:</b> 5 229名调查对象的抗-HEV IgG阳性率为9.19%(95<i>%CI</i>:6.18%~12.20%),较2006年调查结果(11.47%,95<i>%CI:</i> 8.92%~14.02%)下降19.88%;抗-HEV IgG阳性率随年龄增加而增高(χ(2)(趋势)=288.11,<i>P<</i>0.001),与2006年趋势相同。除1~4岁年龄组抗-HEV IgG与2006年基本持平外,其余各年龄组阳性率均低于2006年相应年龄组。2014年山东省城市人群抗-HEV IgG阳性率(8.19%,95<i>%CI:</i> 0.00~22.23%)低于农村(9.69%,95<i>%CI</i>:4.99%~14.38%),东部(12.70%,95<i>%CI</i>:0.00~27.72%)高于中部(4.74%,95<i>%CI</i>:0.00~9.91%)和西部(9.32%,95<i>%CI</i>:0.69%~17.94%),且以上地区抗-HEV IgG阳性率均低于2006年相应地区(11.39%,95<i>%CI:</i> 8.17%~14.62%;11.92%,95<i>%CI:</i> 8.75%~15.08%;22.77%,95<i>%CI</i>:14.99%~30.55%;7.97%,95<i>%CI</i>:4.75%~11.20%;10.59%,95<i>%CI</i>:6.37%~14.82%)。2014年沿海(16.56%,95<i>%CI</i>:12.94%~20.18%)、内陆(7.63%,95<i>%CI</i>:5.16%~10.10%)人群抗-HEV IgG阳性率均低于2006年(28.04%,95<i>%CI</i>:20.45%~35.64%;9.50%,95<i>%CI</i>:7.31%~11.70%)。2014年,农民(11.98%,95<i>%CI</i>:8.20%~15.76%)、工人(9.68%,95<i>%CI</i>:4.48%~14.88%)、干部(13.90%,95<i>%CI</i>:7.47%~20.33%)、公共场所服务人员(12.26%,95<i>%CI</i>:1.80%~22.73%),抗-HEV IgG阳性率亦均低于2006年调查相应人群(13.76%,95<i>%CI</i>:10.15%~17.38%;21.11%,95<i>%CI</i>:12.67%~29.55%;17.81%,95<i>%CI</i>:7.63%~28.00%;21.08%,95<i>%CI</i>:0.03%~42.12%)。 <b>结论:</b> 近年来山东省自然人群戊型肝炎阳性率有所下降,但流行特征未发生明显变化;人群易感性较高,应在高危人群中推广使用戊型肝炎疫苗。.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28693081.001).
  • [ISSN] 0253-9624
  • [Journal-full-title] Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
  • [ISO-abbreviation] Zhonghua Yu Fang Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Keywords] NOTNLM ; Hepatitis E / Hepatitis E virus / Seroepidemiologic studies
  •  go-up   go-down